Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temporary ADT in High-Risk Prostate Cancer After Surgery
NCT00937768Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Jul 2009
- Primary completion
- Jun 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide, goserelin in prostate adenocarcinoma, sponsored by Mayo Clinic. Started Jul 2009; status: terminated.
02
Drugs
leuprolidegoserelin
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT00937768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937768.